BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 20397486)

  • 1. Epidemiology of the four major cancers in South Dakota.
    Clarke J
    S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four major cancers that affect South Dakotans and the U.S. population: breast, colorectal, lung and prostate.
    Vogt HB; Hansen K
    S D Med; 2010; Spec No():5. PubMed ID: 20401982
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology of cancer in the United States.
    Cresanta JL
    Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer rates and deaths from cancers continued to decline between 1992 and 1998.
    Health Care Strateg Manage; 2001 Jul; 19(7):7-8. PubMed ID: 11464573
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of radiation therapy in the management of lung, prostate and colorectal cancer in South Dakota.
    Swartz MJ; Petereit DG
    S D Med; 2010; Spec No():60-6. PubMed ID: 20397493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer: to screen or not to screen? A payer's perspective.
    Amundson EP
    S D Med; 2010; Spec No():72. PubMed ID: 20397494
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in in-patient hospital utilization and surgical procedures for breast, prostate, lung and colorectal cancers in Canada.
    Neutel CI; Gao RN; Wai E; Gaudette LA
    Cancer Causes Control; 2005 Dec; 16(10):1261-70. PubMed ID: 16215877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment.
    Stotts RC
    Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
    Kolb GF
    Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe.
    Znaor A; van den Hurk C; Primic-Zakelj M; Agius D; Coza D; Demetriou A; Dimitrova N; Eser S; Karakilinc H; Zivkovic S; Bray F; Coebergh JW
    Eur J Cancer; 2013 May; 49(7):1683-91. PubMed ID: 23265703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
    McCredie M; Macfarlane GJ; Bell J; Coates M
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
    Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 16. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
    Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
    Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity--United States, 1990-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jan; 51(3):49-53. PubMed ID: 11843259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.